Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
C348066-5mg | 5mg | In stock | $117.90 | |
C348066-25mg | 25mg | In stock | $402.90 | |
C348066-100mg | 100mg | In stock | $1,450.90 |
Synonyms | Cucurbitacin B|6199-67-3|Amarine|Datisca principle B|DATISCACIN|Datiscn Principle B|(+)-Cucurbitacin B|1,2-Dihydro-alpha-elaterin|0115W5MABF|CHEBI:3941|CUCURBITACIN R - DATISCA PRINCIPLE B|NSC49451|NSC-49451|NSC-144154|Cucurbitacin B hydrate|(R,E)-6-((2S, |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Cucurbitacin B also exhibits anti-cancer activity by inhibiting telomerase and c-Myc in breast cancer. It also exhibits anti- artherosclerotic activity. Cucurbitacin B also possesses anti-inflammatory and anti-microbial activity. Cucurbitacin B is a trite |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Grade | Moligand™ |
Action Type | AGONIST |
Mechanism of action | Agonist of TAS2R10 |
Product Description | Application: Cucurbitacin B hydrate has been used: as a signal transducer and activator of transcription 3 (stat3) inhibitor to determine its effect on the expression of human lysosomal acid lipase (hLAL) in myeloid-derived suppressor cells (MDSCs). as an ecdysone receptor (EcR) antagonist injection to lower the levels of 20-hydoxyecdysone (20E) signaling in butterflies. to determine its effect on the cell viability of pancreatic cancer cell lines. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate |
---|---|
INCHI | InChI=1S/C32H46O8/c1-17(33)40-27(2,3)13-12-23(36)32(9,39)25-21(35)15-29(6)22-11-10-18-19(14-20(34)26(38)28(18,4)5)31(22,8)24(37)16-30(25,29)7/h10,12-13,19-22,25,34-35,39H,11,14-16H2,1-9H3/b13-12+/t19-,20+,21-,22+,25+,29+,30-,31+,32+/m1/s1 |
InChi Key | IXQKXEUSCPEQRD-DKRGWESNSA-N |
Canonical SMILES | CC(=O)OC(C)(C)C=CC(=O)C(C)(C1C(CC2(C1(CC(=O)C3(C2CC=C4C3CC(C(=O)C4(C)C)O)C)C)C)O)O |
Isomeric SMILES | CC(=O)OC(C)(C)/C=C/C(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C[C@@H](C(=O)C4(C)C)O)C)C)C)O)O |
Alternate CAS | 6199-67-3 |
PubChem CID | 5281316 |
NSC Number | 49451 |
MeSH Entry Terms | cucurbitacin B;cucurbitacin B 2-sulfate |
Molecular Weight | 558.7 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2310017 | Certificate of Analysis | Dec 19, 2022 | C348066 |
C2310217 | Certificate of Analysis | Dec 19, 2022 | C348066 |
C2310218 | Certificate of Analysis | Dec 19, 2022 | C348066 |
Sensitivity | Moisture & heat sensitive |
---|
Pictogram(s) | GHS06 |
---|---|
Signal | Danger |
Hazard Statements | H300:Fatal if swallowed |
Precautionary Statements | P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P301+P316:IF SWALLOWED: Get emergency medical help immediately. |